In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein.
about
Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Towards a ligand targeted enzyme prodrug therapy: single round panning of a beta-lactamase scaffold library on human cancer cells.Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIADeveloping bifunctional beta-lactamase molecules with built-in target-recognizing module for prodrug therapy: identification of Enterobacter Cloacae P99 cephalosporinase loops suitable for randomization and phage-display selection.Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.Development of antibodies for cancer therapy.Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.Radiation- and photo-induced activation of 5-fluorouracil prodrugs as a strategy for the selective treatment of solid tumors.Antibody-enzyme fusion proteins for cancer therapy.Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination.Immunolabeling of CD3-positive lymphocytes with a recombinant single-chain antibody/alkaline phosphatase conjugate.
P2860
Q33230098-A0FB7865-AF19-4451-B2C6-327532CC8789Q33272567-AC475668-9445-475F-93D5-3ED46763C758Q33377139-59A51EA1-1FD4-40BF-97AA-83A886FDCC58Q33444939-4331D826-17D1-42BD-9C27-85A4C1EC3148Q34152633-E60CAF37-7A2A-4BAC-8840-399D461B2783Q34577226-13BB7A78-71AE-4888-97D2-F4B82B1E180EQ36541958-0BAA062C-E243-4F41-BBF1-D27BAE019359Q36816741-35D47F5B-92BE-47CC-A8E9-8F291100C3E3Q37284613-DB3BCBFD-9F25-402F-B21D-A3D1F44F0099Q37842324-0904B4FF-67F8-41C9-962B-FFE99FABF5A8Q38795816-1187942E-0151-45C7-B243-67CFD32A92B2Q38979784-BCE08C28-E76F-460C-A4D8-37CD4C40339CQ40889838-3A91FD08-B649-4D7A-B8F8-2AF11DA95407
P2860
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
In vitro and in vivo character ...... :anti-CEA scFv fusion protein.
@en
type
label
In vitro and in vivo character ...... :anti-CEA scFv fusion protein.
@en
prefLabel
In vitro and in vivo character ...... :anti-CEA scFv fusion protein.
@en
P2093
P1476
In vitro and in vivo character ...... :anti-CEA scFv fusion protein.
@en
P2093
Chester KA
Michael NP
Nicholas W
Sherwood RF
P356
10.1016/1380-2933(96)00033-4
P577
1996-02-01T00:00:00Z